Patients can still work with their primary care provider or insurance for lab work and management of other chronic conditions while paying out of pocket for the weight loss medication itself
In large-scale clinical trials, the average weight loss was up to 28.7% in 68 weeks
It is important to note that cross-trial comparisons have significant limitations
In patients with treatment-refractory dumping syndrome, surgical reintervention or continuous enteral feeding can be considered, but the outcomes of such approaches are variable
GLP-1R activation also promotes hippocampal neurogenesis, enhances spatial memory, and modulates dopaminergic and serotonergic pathways involved in mood and reward [10,[23], [24], [25], [26], [27]]